Research Methodology

Page 8

Recently published articles about Research Methods and Statistics

Article

Placebo-Controlled, Antidepressant Clinical Trials Cannot Be Shortened to Less Than 4 Weeks' Duration: A Pooled Analysis of Randomized Clinical Trials Employing a Diagnostic Odds Ratio-Based Approach

November 2, 2010

Maurizio Fava, George I. Papakostas, Enrico Tedeschini

Original Research

Qualitative Methods in Early-Phase Drug Trials: Broadening the Scope of Data and Methods From an RCT of N-Acetylcysteine in Schizophrenia

September 21, 2010

Philippe Conus, Michael Berk, Gin S. Malhi, et al

Commentary

Two Clinical Trial Designs to Examine Personalized Treatments for Psychiatric Disorders

July 13, 2010

Andrew C. Leon

Commentary

Closing the Efficacy-Effectiveness Gap: Translating Both the What and the How From Randomized Controlled Trials to Clinical Practice

April 15, 2009

Maurizio Fava, Anthony P. Weiss, Jenny Guidi

ASCP Corner

Is the Problem of a High Placebo Response Unique to Antidepressant Trials?

December 31, 2008

Arif Khan, Amritha Bhat

Original Research

The History and Current State of Antidepressant Clinical Trial Design: A Call to Action for Proof-of-Concept Studies

October 31, 2008

Maurizio Fava, Madhukar H. Trivedi, Michael E. Thase, et al

Original Research

Reach of Benchmark Psychiatric Trial Results to Community-Based Providers: A Case Study of CATIE

July 31, 2008

Timothy J. Petersen, Anthony P. Weiss, Jeff C. Huffman, et al

Letter to the Editor

Increasing Rates of Placebo Response Over Time in Mania Studies

March 18, 2008

Nuria Cruz, Eduard Vieta

Article

Clinical Trials and Tribulations: Perspectives on Research Career Development

March 14, 2008

Marlene P. Freeman

Letter to the Editor

More on Placebo Response

December 14, 2007

Jeffrey Allan Mattes

Original Research

Mortality Risk in Patients With Schizophrenia Participating in Premarketing Atypical Antipsychotic Clinical Trials

December 14, 2007

Arif Khan, Kelly Schwartz, Chelsea Stern, et al

Letter to the Editor

Research Methodology

Recently published articles about Research Methods and Statistics

Placebo-Controlled, Antidepressant Clinical Trials Cannot Be Shortened to Less Than 4 Weeks' Duration: A Pooled Analysis of Randomized Clinical Trials Employing a Diagnostic Odds Ratio-Based Approach

Qualitative Methods in Early-Phase Drug Trials: Broadening the Scope of Data and Methods From an RCT of N-Acetylcysteine in Schizophrenia

Two Clinical Trial Designs to Examine Personalized Treatments for Psychiatric Disorders

Closing the Efficacy-Effectiveness Gap: Translating Both the What and the How From Randomized Controlled Trials to Clinical Practice

Is the Problem of a High Placebo Response Unique to Antidepressant Trials?

The History and Current State of Antidepressant Clinical Trial Design: A Call to Action for Proof-of-Concept Studies

ELSEWHERE:

FOLLOW US:

Research Methodology

Recently published articles about Research Methods and Statistics

Placebo-Controlled, Antidepressant Clinical Trials Cannot Be Shortened to Less Than 4 Weeks' Duration: A Pooled Analysis of Randomized Clinical Trials Employing a Diagnostic Odds Ratio-Based Approach

Qualitative Methods in Early-Phase Drug Trials: Broadening the Scope of Data and Methods From an RCT of N-Acetylcysteine in Schizophrenia

Two Clinical Trial Designs to Examine Personalized Treatments for Psychiatric Disorders

Closing the Efficacy-Effectiveness Gap: Translating Both the What and the How From Randomized Controlled Trials to Clinical Practice

Is the Problem of a High Placebo Response Unique to Antidepressant Trials?

The History and Current State of Antidepressant Clinical Trial Design: A Call to Action for Proof-of-Concept Studies

Reach of Benchmark Psychiatric Trial Results to Community-Based Providers: A Case Study of CATIE

Increasing Rates of Placebo Response Over Time in Mania Studies

Clinical Trials and Tribulations: Perspectives on Research Career Development

More on Placebo Response

Mortality Risk in Patients With Schizophrenia Participating in Premarketing Atypical Antipsychotic Clinical Trials

Sponsored Clinical Trials and Bias

Consensus Report on XT Use in Practice

Subscribe to readmore articles

Subscribe to read
more articles